Veterinary Medicine Information website

SERUM TRIVALENT EQUIN

Authorised
  • Immunoglobulins against Pasteurella multocida, serogroup D, Equine
  • Immunoglobulins against Escherichia coli O8, Equine
  • Immunoglobulins against Salmonella enterica subsp. enterica, serovar Dublin, H antigens, Equine
  • Immunoglobulins against Salmonella enterica subsp. enterica, serovar Typhimurium, H antigens, Equine
  • Immunoglobulins against Escherichia coli O9, Equine
  • Immunoglobulins against Salmonella enterica subsp. enterica, serovar Dublin, O antigens, Equine
  • Immunoglobulins against Salmonella enterica subsp. enterica, serovar Typhimurium, O antigens, Equine
  • Immunoglobulins against Escherichia coli O15, Equine
  • Immunoglobulins against Escherichia coli O78, Equine
  • Immunoglobulins against Escherichia coli O101, Equine
  • Immunoglobulins against Escherichia coli O117, Equine
  • Immunoglobulins against Pasteurella multocida, serogroup A, Equine
Download as PDF

Product identification

Medicine name:
SERUM TRIVALENT EQUIN
Active substance:
  • Immunoglobulins against Pasteurella multocida, serogroup D, Equine
  • Immunoglobulins against Escherichia coli O8, Equine
  • Immunoglobulins against Salmonella enterica subsp. enterica, serovar Dublin, H antigens, Equine
  • Immunoglobulins against Salmonella enterica subsp. enterica, serovar Typhimurium, H antigens, Equine
  • Immunoglobulins against Escherichia coli O9, Equine
  • Immunoglobulins against Salmonella enterica subsp. enterica, serovar Dublin, O antigens, Equine
  • Immunoglobulins against Salmonella enterica subsp. enterica, serovar Typhimurium, O antigens, Equine
  • Immunoglobulins against Escherichia coli O15, Equine
  • Immunoglobulins against Escherichia coli O78, Equine
  • Immunoglobulins against Escherichia coli O101, Equine
  • Immunoglobulins against Escherichia coli O117, Equine
  • Immunoglobulins against Pasteurella multocida, serogroup A, Equine
Target species:
  • Equid
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Immunoglobulins against Pasteurella multocida, serogroup D, Equine
    1.00
    log10 ELISA unit
    /
    1.00
    millilitre(s)
  • Immunoglobulins against Escherichia coli O8, Equine
    1.50
    slow agglutination test unit(s)
    /
    1.00
    millilitre(s)
  • Immunoglobulins against Salmonella enterica subsp. enterica, serovar Dublin, H antigens, Equine
    1.50
    slow agglutination test unit(s)
    /
    1.00
    millilitre(s)
  • Immunoglobulins against Salmonella enterica subsp. enterica, serovar Typhimurium, H antigens, Equine
    1.50
    slow agglutination test unit(s)
    /
    1.00
    millilitre(s)
  • Immunoglobulins against Escherichia coli O9, Equine
    1.50
    slow agglutination test unit(s)
    /
    1.00
    millilitre(s)
  • Immunoglobulins against Salmonella enterica subsp. enterica, serovar Dublin, O antigens, Equine
    1.50
    slow agglutination test unit(s)
    /
    1.00
    millilitre(s)
  • Immunoglobulins against Salmonella enterica subsp. enterica, serovar Typhimurium, O antigens, Equine
    1.50
    slow agglutination test unit(s)
    /
    1.00
    millilitre(s)
  • Immunoglobulins against Escherichia coli O15, Equine
    1.50
    slow agglutination test unit(s)
    /
    1.00
    millilitre(s)
  • Immunoglobulins against Escherichia coli O78, Equine
    1.50
    slow agglutination test unit(s)
    /
    1.00
    millilitre(s)
  • Immunoglobulins against Escherichia coli O101, Equine
    1.50
    slow agglutination test unit(s)
    /
    1.00
    millilitre(s)
  • Immunoglobulins against Escherichia coli O117, Equine
    1.50
    slow agglutination test unit(s)
    /
    1.00
    millilitre(s)
  • Immunoglobulins against Pasteurella multocida, serogroup A, Equine
    1.00
    log10 ELISA unit
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Equid
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI05AM
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/3469350 4/1982
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
Download